TheAnswerPage

JULY 1, 2022

On June 21, 2022, Purdue Pharma announced that Nalmefene HCl Injection, 2mg/2mL (1mg/1mL) is now available in the U.S. For what condition is Nalmefene HCl indicated? for the Treatment of Known or Suspected Overdose with Natural or Synthetic Opioids. June 21, 2022. See the Answer.

Treatment 75

Treatment Conditions Cannabis 75

CannaMD

MAY 21, 2022

Finding the best treatment for autism has been a lifelong journey for many parents and caretakers. There is currently no known cure for autism, but with medical cannabis, there is hope for safe and effective treatment for autism symptoms.

Treatment 98

Treatment Cannabis Conditions 98

Project CBD

FEBRUARY 28, 2023

5 In June 2018, the FDA approved Epidiolex® (GW Pharmaceuticals; Cambridge, UK), the first FDA-approved pharmaceutical drug to contain a “purified drug substance [CBD] derived from marijuana,” for the treatment of seizures associated with two rare epilepsy disorders. Available at: [link] Accessed October 17, 2022. February 2, 2022.

CBD 144

CBD Seed-To-Sale Food Access 144

MMJ Recs

MARCH 10, 2022

Getting a Pennsylvania medical marijuana card 2022 is a straightforward process. It exists to help Pennsylvania residents who suffer from a wide range of medical conditions to live more fulfilling lives. The process of applying for your Pennsylvania MMJ card in 2022 is easy to navigate and can be done entirely online.

Dispensary 52

Dispensary Conditions Treatment Epilepsy 52

The Cannigma

JULY 12, 2022

Roll out of the program has been slow, and as of June 2022, there were still no doctors certified to issue prescriptions, no licensed dispensaries, and no legal farming of cannabis products. Unlike other states, Alabama requires doctors to document a failure of conventional medical treatment before issuing a medical cannabis prescription.

Legalization 122

Legalization Chronic Pain Programs Epilepsy 122

MMJ Recs

MARCH 15, 2022

If you’ve decided that this is the year that you’d like to try MMJ treatment, read on for our guide on how to get your Missouri MMJ card in 2022 – and all the benefits it can bring you. Other conditions that are considered terminal/chronic may also qualify for a Missouri MMJ card. Read on for an outline of the process!

Conditions 52

Conditions Treatment Epilepsy Dispensary 52

MMJ Recs

JANUARY 15, 2022

Today, we’ll go through the process of how to get a medical marijuana card in Iowa in 2022. The list of qualifying conditions for Iowa MMJ is relatively long and inclusive. So, how do I get my Iowa MMJ card in 2022? What Are The Qualifying Conditions For A Medical Card In Iowa In 2022? Yes, you can!

Chronic Pain 52

Chronic Pain Dispensary Conditions Programs 52

Veriheal

JANUARY 26, 2023

Bipolar disorder is a complex condition that impacts millions worldwide, leading to extreme mood swings, intense emotional episodes, and difficulty managing day-to-day life. Further exploration of this possibility is underway to provide better care and more effective therapies for individuals living with the condition.

Treatment 98

Treatment Cannabinoids Conditions Pharmaceutical 98

MMJ Recs

JANUARY 25, 2022

So now that medical marijuana is finally available in Ohio, how do you get an Ohio MMJ card in 2022? Not all doctors in Ohio are certified to recommend medical marijuana treatment. How Do I Get My Ohio MMJ Card In 2022? What Are The Qualifying Conditions For A Medical Card In Ohio In 2022? Read on to find out!

Dispensary 52

Dispensary Chronic Pain Programs Treatment 52

MMJ Recs

FEBRUARY 4, 2022

If you’ve decided that this is the year you want to start using MMJ to alleviate your symptoms, read on for more information on how to get your Oklahoma MMJ card in 2022. Residents of the state of Oklahoma qualify for an OK MMJ card provided that they have a medical condition that a licensed state physician deems suitable for MMJ treatment.

Conditions 52

Conditions Treatment Edibles Patients 52

Veriheal

MARCH 20, 2023

Using psilocybin in small doses, or microdosing, has been shown to aid in the treatment of various mental health issues, including anxiety, depression, PTSD, and obsessive-compulsive disorder. Smith cited results from clinical trials showing that MDMA holds promise in the treatment of PTSD. Connecticut Gov. Minnesota Rep. Missouri Rep.

Clinical Trials 98

Clinical Trials Therapy Decriminalization Treatment 98

The Cannigma

FEBRUARY 1, 2023

Individuals who use cannabis-based medications often want to cure their cancer, not just reduce the symptoms that come with the condition. Work together to weigh the potential benefits and risks specific to your medical condition, and track the progress of your cancer along with your cannabis regimen. 1 So can cannabis cure cancer?

Clinical Trials 145

Clinical Trials Research and Development Therapy Cannabinoids 145

Leafwell

JANUARY 11, 2022

Anxiety is a common mental health condition that is on the rise. Only about 37 percent of people afflicted with anxiety receive treatment. According to the Anxiety and Depression Association of America (ADAA), 40 million U.S. adults grapple with anxiety disorders each year. The 63 percent of anxiety-plagued.

CBD 63

CBD Treatment Conditions Cannabis 63

Illinois News Joint

FEBRUARY 8, 2023

With a philosophy rooted in trauma-informed care, they believe in client-led healing and strive to truly listen and collaborate with patients to create individualized treatment plans that meet unique needs and lifestyles. We work with patients of all ages with a wide variety of conditions.

Patients 98

Patients Treatment Environment Conditions 98

The Cannigma

JUNE 25, 2022

Poland established a medical cannabis program in 2017, which allows for a range of cannabis products to be prescribed for a range of medical conditions. Qualifying conditions include chronic pain, multiple sclerosis, spasticity, chemo-induced nausea, and treatment-resistant epilepsy. Poland and cannabis.

Legalization 108

Legalization Supply Chain Chronic Pain Tincture 108

Leaf Science

JULY 12, 2019

As legalization continues to be passed worldwide we hope (and will continue to educate) to see cannabis federally legal in the US and in most countries by 2022. As the debate over legalizing marijuana heats up, many continue to dispute the value of marijuana as a treatment for various ailments.

Indica 95

Indica Marijuana Treatment Medicine 95

Cannabis Law Report

OCTOBER 1, 2021

TD-0148A is currently in preclinical pharmacology and other IND-enabling studies and in 2022, BetterLife will file its IND and start Phases 1 and 2 in healthy subjects for major depressive disorder. BetterLife is already in advanced stages of GMP manufacturing TD-0148A and initiated the necessary preclinical IND-enabling studies for TD-0148A.

Treatment 52

Treatment Conditions Media 52

The Cannigma

JULY 5, 2022

The program was legalized in 2015 and patients with qualifying conditions can get a prescription for up to 20oz of low THC oil, capsules, patches, or lotion. But it is a medical program in name only, because as of June 2022 there were no licensed dispensaries in Georgia. In 2015, Georgia legalized possession of up 20 fl.

Law 95

Law Decriminalization Programs Patients 95

Veriheal

JANUARY 24, 2023

With its abundance of medicinal properties and non-addictive nature, why does marijuana remain an untapped resource for researchers wanting to find treatments for debilitating chronic diseases like Parkinson’s? Do not attempt to self-diagnose or prescribe treatment based on the information provided. So what gives?

DEA 98

DEA Treatment Medicine Pets 98

Veriheal

SEPTEMBER 7, 2022

On July 6, 2022, Washington, D.C. The Medical Marijuana Self-Certification Temporary Amendment Act of 2022 currently permits D.C. law—specifically, the Legalization of Marijuana for Medical Treatment Initiative of 1999—for a total of 225 days. implemented a revolutionary emergency amendment to its medical cannabis program.

Patients 98

Patients Programs Access Treatment 98

Cannabis Law Report

JUNE 18, 2021

Atai is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. ATAI expects to initiate a Phase 2 trial for another program in 2021 and an additional three Phase 2 trials for other programs in 2022. One of its companies, Recognify Life Sciences, has initiated a Phase 2a trial in the US.

Treatment 89

Treatment Therapy Programs Conditions 89

Veriheal

MAY 2, 2022

Of all the diseases and medical conditions that humans face the risk of being diagnosed with—even people who lead the healthiest of lifestyles—cancer is one of the most prevalent and deadly. With more treatment options (such as cannabis), more lives can be saved and less heartbreak can ensue across the globe. neuropathic cancer pain).

Treatment 98

Treatment Clinical Trials Patients Medicine 98

Veriheal

FEBRUARY 9, 2023

Although many rely on imaging scans to diagnose illnesses and get treatment of various kinds, getting into the enclosed chamber can be stressful. However, it is important to note that the study took place with a small sample size under controlled conditions.

Clinical Trials 98

Clinical Trials Research and Development Data Collective 98

TheAnswerPage

AUGUST 26, 2022

This question begins “The Answer of the Day” series on the treatment effects of cannabinoids…. Has it been shown that any cannabinoids have a significant therapeutic effect on a health condition? BMC Med 20, 259 (2022). Efficacy, retention and the adverse events of medical cannabinoids were examined. Spanagel, R.

Cannabinoids 40

Cannabinoids Epilepsy Treatment Conditions 40

TheAnswerPage

FEBRUARY 26, 2022

Have any states legalized the use of cannabis for medicinal purposes since the start of 2022? states in legalizing marijuana for medical use in February, 2022. Yes, Mississippi joined 36 other U.S.

Treatment 40

Treatment Legislation Conditions Medicine 40

MMJ Recs

DECEMBER 15, 2021

This means that MMJ patients from other states will be able to purchase recreational marijuana in New York from late 2022. In order to get a New York medical marijuana card, a person must be a resident of New York State or be temporarily residing in the state for the purpose of receiving treatment. web portal.

Chronic Pain 98

Chronic Pain Dispensary Recreational Patients 98

MMJ Recs

NOVEMBER 14, 2022

Medical marijuana helps to improve the lives of Maryland residents who suffer from a wide range of medical conditions. Maryland voters will get to vote on whether recreational marijuana should become legal in the state in November 2022. What Are The Qualifying Conditions For Medical Marijuana In Maryland? Wasting syndrome.

Dispensary 105

Dispensary Patients Programs Recreational 105

Veriheal

JUNE 19, 2023

The psychedelic drugs here include LSD, MDMA, psilocybin, ketamine, and ayahuasca, which are in high demand for mental health treatment and other therapeutic reasons. As of 2022, the global psychedelics market was valued at $4.87 billion in the next six years. MDMA has given compelling results in treating people with PTSD.

Therapy 111

Therapy Treatment Patients Policy 111

Veriheal

NOVEMBER 21, 2023

As we reflect on the success of the 2022 recipients, we are thrilled to introduce the exceptional winners of the 2023 scholarship. To alleviate this burden, we awarded $5,000 scholarships to five outstanding individuals in 2022. Veriheal recognizes the financial challenges students face in pursuing higher education.

Research and Development 110

Research and Development Consumption Education Data 110

Cannabis Law Report

JULY 13, 2022

Here’s what they posted 12 July 2022. Import, Advertising and Supply Compliance Priorities 2022-23. 12 July 2022. Import, Advertising and Supply Compliance Priorities 2022-23. Compliance Priority. Deter and address the unlawful import, advertising and supply of unapproved therapeutic goods associated with COVID-19.

Compliance 52

Compliance Compliance Wellness and Beauty Vaping 52

Cannabis Law Report

FEBRUARY 19, 2022

The AMCC anticipates that applicants may submit licenses to grow and/or manufacture medical cannabis on September 1, 2022. Under current law , the Florida Department of Health (FDOH) is responsible for overseeing the medical cannabis program, including issuing licenses to medical cannabis treatment centers.

Legalization 97

Legalization Seed-To-Sale Programs Dispensary 97

Illinois News Joint

APRIL 27, 2024

Suzanne Mulvehill is a Clinical Sexologist, Orgasmologist, and the Executive Director of the Female Orgasm Research Institute , which is dedicated to conducting research and identifying scientifically based treatments to reduce the persistently high percentage of women suffering from orgasm difficulty and its co-morbid conditions.

Research and Development 105

Research and Development Events Environment Education 105

Kind Meds (Cannabis Education Blog)

APRIL 25, 2022

If stress is not managed properly, it often lingers, leading to serious mental and physical conditions, such as insomnia, recurring headaches, eating disorders, a weakened immune system, high blood pressure, heart disease, and much more. [1] Retrieved March 29, 2022, from … Continue reading. 1] Khan, S., & Kahn, R.

Strains 98

Strains Marijuana Sativa Hybrid 98

TheAnswerPage

AUGUST 27, 2022

“The Answer of the Day” series on the treatment effects of cannabinoids continues… According to randomized controlled trials, which health conditions does dronabinol (Marinol – a synthetic THC product) effectively treat? BMC Med 20, 259 (2022). Spanagel, R. See the Answer.

Chronic Pain 40

Chronic Pain Cannabinoids Treatment THC 40

TheAnswerPage

AUGUST 28, 2022

“The Answer of the Day” series on the treatment effects of cannabinoids continues… According to randomized controlled trials, which health conditions does nabiximols (Sativex – ~50:50 THC:CBD plant-derived product) effectively treat? BMC Med 20, 259 (2022). Spanagel, R. See the Answer.

Chronic Pain 40

Chronic Pain Therapy Sleep Cannabinoids 40

Cannabis Law Report

JANUARY 3, 2022

Affirms expectations for initial topline results in 1H 2022. regulatory path; company expects to submit IND in 1Q 2022. We continue to anticipate reporting initial topline results from Part A of this trial in the first half of 2022, as we closely monitor the impact of COVID-19. Chief Executive Officer of Anebulo. Rex Merchant.

Pharmaceutical 52

Pharmaceutical Cannabinoids Treatment Clinical Trials 52

Cannabis Law Report

SEPTEMBER 29, 2022

Australia’s drugs regulator issues 73 infringement notices over claims prescriptions could treat conditions such as cancer and epilepsy. 27 September 2022. It is also alleged that the unlawful advertising included unapproved references to the treatment of serious diseases or conditions, including in some cases cancer and epilepsy.

Epilepsy 52

Epilepsy Conditions Media Medicine 52